• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Cue Health

Cue Health, Major League Baseball partner on COVID-19 testing

April 1, 2022 By Sean Whooley

Cue Health (Nasdaq:HLTH) and Major League Baseball (MLB) announced today that will expand on league-wide COVID-19 testing. Under a national partnership, Cue Health — MLB’s trusted at-home testing solution — will provide MLB clubs as well as the league office with its integrated care platform that includes the portable and reusable Cue Health monitoring system […]

Filed Under: Business/Financial News, Diagnostics, Genomics/Molecular Diagnostics, Health Technology Tagged With: coronavirus, COVID-19, Cue Health

Cue Health launches direct-to-consumer virtual health platform

November 9, 2021 By Sean Whooley

Cue Health (NSDQ:HLTH) announced today that it will launch its direct-to-consumer virtual health program on Nov. 15, 2021. San Diego-based Cue Health’s virtual health platform includes what it says is a first-of-its kind molecular COVID-19 test through its new eCommerce site and in-app shop. The company said in a news release that it makes the […]

Filed Under: Big Data, Business/Financial News, Diagnostics, Digital Health, Electronic Medical Records (EMR), Featured, Genomics/Molecular Diagnostics, Health Technology, Software / IT Tagged With: Cue Health

MedTech 100 roundup: More growth ahead?

May 24, 2021 By Sean Whooley

A turgid month for the medtech industry might be drifting into the past after the past week indicated a slight turnaround as summer nears. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished the week at 107.74 points, marking a 1.4% rise from the 106.22-point mark set one […]

Filed Under: Business/Financial News, Funding Roundup, Mergers & Acquisitions, Wall Street Beat Tagged With: BD, coronavirus, COVID-19, Cue Health, DarioHealth Corp, DeviceTalks Weekly, Fractyl Laboratories, Giiant Pharma, Google, MedTech 100 Index, Memic Innovative Surgery, Teleflex

Cue Health raises $235M to support its over-the-counter, home-use diagnostics

May 14, 2021 By Sean Whooley

Healthcare technology company Cue Health announced that it closed a private financing round worth $235 million. Existing investors Johnson & Johnson Innovation — JJDC, Decheng Capital, CAVU Ventures, ACME Capital and more contributed to the financing, as did new investors Perceptive Advisors, MSD Capital and Koch Strategic Platforms, according to a news release. Morgan Stanley […]

Filed Under: Business/Financial News, Diagnostics, Digital Health, Featured, Funding Roundup, Genomics/Molecular Diagnostics, Health Technology Tagged With: coronavirus, COVID-19, Cue Health

5 at-home COVID-19 diagnostic tests you should know

March 15, 2021 By Danielle Kirsh

The wait for a completely at-home COVID-19 test ended in November when the FDA authorized the first ones that enabled people to obtain samples and results at home. The agency since then has authorized five at-home COVID-19 tests for emergency use since the beginning of the pandemic. The kits are made to take a sample […]

Filed Under: Diagnostics, Featured, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: Abbott, coronavirus, COVID-19, Cue Health, Ellume, FDA, Lucira, Quidel

First OTC molecular test for COVID-19 gains FDA nod

March 5, 2021 By Nancy Crotti

The FDA today issued its first emergency use authorization for a molecular COVID-19 diagnostic test for at-home use without a prescription. The Cue Health COVID-19 Test for Home and Over The Counter (OTC) use is a molecular nucleic acid amplification test designed to detect genetic material from the SARS-CoV-2 virus in the nostrils. The authorized […]

Filed Under: Diagnostics, Featured, Food & Drug Administration (FDA), Genomics/Molecular Diagnostics, Regulatory/Compliance Tagged With: coronavirus, COVID-19, Cue Health, FDA

MedTech 100 roundup: Industry continues its ascent

October 19, 2020 By Sean Whooley

Stocks in the medtech industry maintained their upward trajectory, topping last week’s peak with yet another rise to new heights. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week at 95.66 (Oct. 16), marking a 0.6% gain from the 95.05 points registered at the end of […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, Diagnostics, Featured, Funding Roundup, Genomics/Molecular Diagnostics, Initial Public Offering (IPO), MassDevice Earnings Roundup, Mergers & Acquisitions, Replacement Heart Valves, Research & Development, Structural Heart, Wall Street Beat Tagged With: Boston Scientific, coronavirus, COVID-19, Cue Health, Dept. of Health & Human Services (HHS), Eargo, MedTech 100 Index, Medtronic, Pfizer, Siemens Healthineers, Varian Medical Systems

Cue Health lands $481M from HHS for COVID-19 test

October 14, 2020 By Nancy Crotti

The federal government has awarded startup Cue Health $481 million to increase domestic production capacity of point-of-care testing for COVID-19. The money from the Department of Health and Human Services and the Department of Defense will enable San Diego, Calif.-based Cue to manufacture 100,000 COVID-19 test kits per day by March 2021, including 6 million […]

Filed Under: Business/Financial News, Diagnostics, Funding Roundup, Genomics/Molecular Diagnostics Tagged With: coronavirus, COVID-19, Cue Health

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS